Arteriovenous fistula patency in the 3 years following vonapanitase and placebo treatment

@article{Peden2017ArteriovenousFP,
  title={Arteriovenous fistula patency in the 3 years following vonapanitase and placebo treatment},
  author={Eric K. Peden and T. O’Connor and B. Browne and B. Dixon and A. Schanzer and S. Jensik and A. Sam and S. Burke},
  journal={Journal of Vascular Surgery},
  year={2017},
  volume={65},
  pages={1113–1120}
}
  • Eric K. Peden, T. O’Connor, +5 authors S. Burke
  • Published 2017
  • Medicine
  • Journal of Vascular Surgery
    • Objective: This study explored the long‐term outcomes of arteriovenous fistulas treated with vonapanitase (recombinant human elastase) at the time of surgical creation. Methods: This was a randomized, double‐blind, placebo‐controlled trial of 151 patients undergoing radiocephalic or brachiocephalic arteriovenous fistula creation who were randomized equally to placebo, vonapanitase 10 &mgr;g, or vonapanitase 30 &mgr;g. The results after 1 year of follow‐up were previously reported. The current… CONTINUE READING
    View on Wolters Kluwer
    jvascsurg.org
    10 Citations
    Highly Influential Citations
    1
    Background Citations
    3
    10 Citations
    Citation Type

    Citation Type

    A randomized trial of vonapanitase (PATENCY‐1) to promote radiocephalic fistula patency and use for hemodialysis
    • 15
    Intraoperative pneumatic tourniquet use may improve the clinical outcomes of arteriovenous fistula creations
    Factors affecting arteriovenous fistula dysfunction: A narrative review
    • 8
    Periadventitial Delivery of Simvastatin-Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula.
    • 1
    International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Innovations in vascular access for hemodialysis.
    • 6
    Function of basic fibroblast growth factor in native arteriovenous fistula stenosis of hemodialysis patients
    • PDF
    Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas
    • 2
    • PDF
    Effect of Pore Size and Spacing on Neovascularization of a Biodegradable Shape Memory Polymer Perivascular Wrap.
    • Highly Influenced
    • PDF
    The myristoylated alanine-rich C kinase substrate differentially regulates kinase interacting with stathmin in vascular smooth muscle and endothelial cells and potentiates intimal hyperplasia formation.
    • 1

    References

    SHOWING 1-10 OF 22 REFERENCES
    Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease.
    • 40
    Procedural success and patency after percutaneous treatment of thrombosed autogenous arteriovenous dialysis fistulas.
    • 74
    Salvage of immature forearm fistulas for haemodialysis by interventional radiology.
    • L. Turmel-Rodrigues, A. Mouton, +5 authors J. Pengloan
    • Medicine
    • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
    • 2001
    • 220
    • PDF
    Superior patency of upper arm arteriovenous fistulae in high risk patients.
    • 18
    A Comparison of Transposed Brachiobasilic Fistulae with Nontransposed Fistulae and Grafts in the Fistula First Era
    • 34
    A Multi-center, Dose-escalation Study of Human type I Pancreatic Elastase (PRT-201) Administered after Arteriovenous Fistula Creation
    • 43
    • PDF
    Hemodialysis arteriovenous fistula maturity: US evaluation.
    • 283
    Why don't fistulas mature?
    • B. Dixon
    • Medicine
    • Kidney international
    • 2006
    • 253
    Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions.
    • 650
    Recombinant Human Elastase Alters the Compliance of Atherosclerotic Tibial Arteries After Ex Vivo Angioplasty
    • 6